Related Experiment Videos
Early-onset Parkinson's disease and depression
Délcio Bertucci Filho1, Hélio A G Teive, Lineu C Werneck
1Movement Disorders Unit, Neurology Service, Hospital de Clínicas, Universidade Federal do Paraná, Rua General Carneiro 181, 80060-900 Curitiba, PR, Brazil.
Arquivos De Neuro-Psiquiatria
|April 11, 2007
Summary
Depression affects over a third of early-onset Parkinson's disease (EOPD) patients. Those with depression experienced earlier levodopa complications and worse disease severity.
Area of Science:
- Neurology
- Psychiatry
- Movement Disorders
Background:
- Early-onset Parkinson's disease (EOPD), diagnosed before age 45, presents distinct clinical features compared to late-onset forms.
- The prevalence of depression in EOPD is thought to be higher than in late-onset Parkinson's disease, but specific risk factors remain unidentified.
Purpose of the Study:
- To determine the frequency of depression in patients with EOPD.
- To identify potential clinical differences between EOPD patients with and without depression.
Main Methods:
- A cohort of 45 patients diagnosed with EOPD was assessed for depression.
- Clinical characteristics, including disease severity scales (Hoehn-Yahr, UPDRS, Schwab-England) and levodopa-related complications, were analyzed in relation to depression status.
Main Results:
- Depression was diagnosed in 16 (35.5%) of the EOPD patients studied.
- The incidence of depression in EOPD was higher than in the general population but comparable to late-onset Parkinson's disease.
- EOPD patients with depression showed earlier onset of levodopa-related complications and more severe disease progression across multiple clinical scales.
Conclusions:
- Depression is a significant comorbidity in early-onset Parkinson's disease, affecting over a third of patients.
- While no direct relationship was found between depression and specific clinical characteristics, depression is associated with more rapid disease progression and earlier treatment complications in EOPD.
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...